Liminal BioSciences Inc. LMNL

PreMarket $5.62 thus far

[stockbuphoon]

I think Piper Sandal's future looking report now that Ryplazim is in rear view mirror except for some cash that they will burn at an incredibly $5M a month per Q1 presentation slide. How many clinical trials are ready to go? Unless they pull the Alstrom phase 3 out of the dust bin and Kidney for 4050/Fez, what's next? LMNL could have had this stock run hard with FDA by not announcing stoppage of IPF. What useful purpose did that serve? Did they have to release anything until study was over? They could have raised money at higher stock price as they will need bridge financing to sell the PRV. When are they cutting salaries to $100M market cap level? When are they stripping back admin, sales and marketing to zero? Remember, this is a company that took one year to release information on Complete Response Letter for Ryplazim 1st submittal when they received it in March 2018 so why release the IPF news 4 days before approval? Something else is rotten in the board of directors and management of Liminal. This is truly shady.

[Steve33]

I totally agree. They are doing an incredible job at keeping the share price down. For what purpose. They own most of the shares so they should want it to shoot up. Any guesses as to why?

[stockbuphoon]

I have one theory but it is as evil as the recapitalization where Thomvest got their 71% share when other funding sources were available in late 2018/ early 2019. Tanking things on purpose and Thomvest/ SALP own this puppy? I can't think of any other reason to put that information out there. There is just no logical reason unless there is a surprise new direction announced this week but, on

[Steve33]

That is a possibility but we should be between 20 to 30 dollars with our first BLA and PRV or maybe more. There should have been no deal with Kedrion. We could have kept our blood business and made plasminogen and IVIG at 100 million plus a year. Then added more proteins and the sky is the limit. FDA wouldn't have to approve each new protein and we would be off to the moon. Thompson would make

[Transit77]

Your onto the scam. They are going private to make serious money off the public books. Calculated theft.

[Steve33]

That makes no sense. They make way more money here through share price appreciation. No one wants failure on there resumee and business reputation means everything for guys like Thompson.

[Transit77]

No they want more financing till they steal the company and sell the assets privately. 

[GunnerG]

TV will make their money through the royalty they have with Ryplazim. The SP has no reason to go up in the long term with no revenue, no assets and no pipeline. Steve33, if you want to appear to be credible, get the spelling of the majority SH right.  Its Thomson, not Thompson.

[GunnerG]

Keeping the price down?  Why would it go up to $50 or even $20. There is no future here.  They sold Ryplazim so have no revenue stream, pipeline is a dream and have one asset left in QC.  Not sure why management is making money they are; doing a terrible job for retail SH.